Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review
Open Access
- 28 March 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 13 (1), 285
- https://doi.org/10.1186/1471-2458-13-285
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Limitations of the Framingham risk score are now much clearerPreventive Medicine, 2009
- Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, ArgentinaCost Effectiveness and Resource Allocation, 2009
- Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based studyBMC Public Health, 2008
- Relation of Framingham Risk Score to Subclinical Atherosclerosis Evaluated Across Three Arterial SitesThe American Journal of Cardiology, 2008
- Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in PolandPharmacoEconomics, 2008
- Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)BMJ, 2007
- Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysisThe Lancet, 2006
- The Cost-Effectiveness of Fluvastatin in Hungary Following Successful Percutaneous Coronary InterventionCardiovascular Drugs and Therapy, 2006
- The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the SeychellesTobacco Control, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002